Treatment for MDS will vary depending on symptoms, diagnosis, risk category, disease stage, age, pre-existing conditions, general health, and availability of bone marrow donors. A doctor knowledgeable in cancer and blood can determine the best type and combination of therapy on an individual basis.
Supportive care is not a cure, but the management of symptoms caused by low blood cell counts (cytopenias). To counteract the shortage of red blood cells (anemia) and platelets, a patient’s abnormal blood cells…
In general, indicators of a good MDS prognosis include normal or moderately reduced white blood cell or platelet counts, less than 20 percent of blasts in the bone marrow, and abnormal red blood cells (ringed sideroblasts). Also, young patients typically have a better prognosis than older patients.
By contrast, indicators of poor MDS prognosis include a severe lack of white blood cells or platelets, blast percentages between 20 to 29 percent, and the presence of blasts in the blood (Auer…
 |
Author: Jason Gotlib Book Description: MDS is a lethal blood disease that affects as many as 50 per 100,000 individuals over the age of 70. The disorder is five times more prevalent than AML, a form of leukemia. Whether you’re a newly diagnosed patient, a survivor, or loved one of someone suffering from MDS, this book offers help. The only text available to provide both the doctor’s |
…
 |
Author: Icon Health Publications Book Description: This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to myelodysplastic syndromes (also Chronic myelomonocytic anemia; Dysmyelopoietic syndrome; Hemopoietic dysplasia; |
…